Changing trends in computational drug repositioning

Pharmaceuticals

Volumn 11, Issue 2, 2018, Pages

  Yella, Jaswanth K ^a   Yaddanapudi, Suryanarayana ^a   Wang, Yunguan ^a   Jegga, Anil G ^a,b,c  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c University of Cincinnati   (United States)

Author keywords

computational drug repositioning; crowdsourcing; deep learning; drug discovery; drug repositioning; drug repurposing; machine learning; open innovation

Indexed keywords

ALGORITHM; BIOINFORMATICS; CROWDSOURCING; DATA MINING; DRUG REPOSITIONING; ELECTRONIC HEALTH RECORD; MACHINE LEARNING; REVIEW; TREND STUDY;

EID: 85048326966     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph11020057     Document Type: Review

References (160)

1. Scannell, J.W., Blanckley, A., Boldon, H., Warrington, B. Diagnosing the decline in pharmaceutical R&D efficiency. Nat. Rev. Drug Discov. 2012,11,191-200.
2. Akhondzadeh, S. The Importance of Clinical Trials in Drug Development. Avicenna J. Med. Biotechnol. 2016, 8,151.
3. Plenge, R.M., Scolnick, E.M., Altshuler, D. Validating therapeutic targets through human genetics. Nat. Rev. Drug Discov. 2013,12, 581-594.
4. Kola, I., Landis, J. Can the pharmaceutical industry reduce attrition rates? Nat. Rev. Drug Discov. 2004, 3,1-5.
5. Paul, S.M., Mytelka, D.S., Dunwiddie, C.T., Persinger, C.C., Munos, B.H., Lindborg, S.R., Schacht, A.L. How to improve RD productivity: The pharmaceutical industry's grand challenge. Nat. Rev. Drug Discov. 2010, 9, 203-214.
6. Booth, B., Zemmel, R. Opinion/Outlook: Prospects for productivity. Nat. Rev. Drug Discov. 2004, 3,451-456.
7. Ashburn, T.T., Thor, K.B. Drug repositioning: Identifying and developing new uses for existing drugs. Nat. Rev. Drug Discov. 2004, 3, 673-683.
8. Graul, A.I., Cruces, E., Stringer, M. The year's new drugs & biologics, 2013: Part I. Drugs of Today 2014, 50, 51-100.
9. Hurle, M.R., Yang, L., Xie, Q., Rajpal, D.K., Sanseau, P., Agarwal, P. Computational drug repositioning: From data to therapeutics. Clin. Pharmacol. Ther. 2013, 93, 335-341.
10. Papapetropoulos, A., Szabo, C. Inventing new therapies without reinventing the wheel: The power of drug repurposing. Br. J. Pharmacol. 2018, 2016-2018.
11. Padhy, B.M., Gupta, Y.K. Drug repositioning: Re-investigating existing drugs for new therapeutic indications. J. Postgrad. Med. 2011, 57,153-160.
12. Nosengo, N. Can you teach old drugs new tricks? Nature 2016, 534, 314-316.
13. Sardana, D., Zhu, C., Zhang, M., Gudivada, R.C., Yang, L., Jegga, A.G. Drug repositioning for orphan diseases. Brief. Bioinform. 2011,12, 346-356.
14. Cha, Y., Erez, T., Reynolds, I.J., Kumar, D., Ross, J., Koytiger, G., Kusko, R., Zeskind, B., Risso, S., Kagan, E., et al. Drug repurposing from the perspective of pharmaceutical companies. Br. J. Pharmacol. 2017.
15. Li, J., Zheng, S., Chen, B., Butte, A.J., Swamidass, S.J., Lu, Z. A survey of current trends in computational drug repositioning. Brief. Bioinform. 2016,17, 2-12.
16. Prathipati, P., Mizuguchi, K. Systems Biology Approaches to a Rational Drug Discovery Paradigm. Curr. Top. Med. Chem. 2015,16,1009-1025.
17. Li, Y.Y., Jones, S.J.M. Drug repositioning for personalized medicine. Genome Med. 2012, 4, 27.
18. Jin, G., Wong, S.T.C. Toward better drug repositioning: Prioritizing and integrating existing methods into efficient pipelines. Drug Discov. Today 2014,19, 637-644.
19. Liu, Z., Fang, H., Reagan, K., Xu, X., Mendrick, D.L., Slikker, W., Tong, W. In silico drug repositioning: What we need to know. Drug Discov. Today 2013,18,110-115.
20. Emig, D., Ivliev, A., Pustovalova, O., Lancashire, L., Bureeva, S., Nikolsky, Y., Bessarabova, M. Drug Target Prediction and Repositioning Using an Integrated Network-Based Approach. PLoS ONE 2013, 8.
21. Cheng, F., Liu, C., Jiang, J., Lu, W., Li, W., Liu, G., Zhou, W., Huang, J., Tang, Y. Prediction of drug-target interactions and drug repositioning via network-based inference. PLoS Comput. Biol. 2012, 8.
22. Zhao, S., Li, S. Network-based relating pharmacological and genomic spaces for drug target identification. PLoS ONE 2010, 5.
23. Yang, L., Agarwal, P. Systematic drug repositioning based on clinical side-effects. PLoS ONE 2011, 6.
24. Kinnings, S.L., Liu, N., Buchmeier, N., Tonge, P.J., Xie, L., Bourne, P.E. Drug discovery using chemical systems biology: Repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosis. PLoS Comput. Biol.2009, 5.
25. Jadamba, E., Shin, M. A Systematic Framework for Drug Repositioning from Integrated Omics and Drug Phenotype Profiles Using Pathway-Drug Network. BioMed Res. Int. 2016, 2016.
26. Li, J., Lu, Z. Pathway-based drug repositioning using causal inference. BMC Bioinform. 2013,14.
27. Kotelnikova, E., Yuryev, A., Mazo, I., Daraselia, N. Computational approaches for drug repositioning and combination therapy design. J. Bioinform. Comput. Biol. 2010, 8, 593-606.
28. Cramer, P., Cirrito, J., Wesson, D. ApoE-Directed Therapeutics Rapidly Clear beta-Amyloid and Reverse Deficits in AD Mouse Models. Science 2012, 335,1503-1506.
29. Sivachenko, A., Kalinin, A., Yuryev, A. Pathway Analysis for Design of Promiscuous Drugs and Selective Drug Mixtures. Curr. Drug Discov. Technol. 2006, 3, 269-277.
30. Strittmatter, W.J. Old drug, new hope for Alzheimer's disease. Science 2012, 335, 1447-1448.
31. Jin, G., Zhao, H., Zhou, X., Wong, S.T.C. An enhanced Petri-Net model to predict synergistic effects of pairwise drug combinations from gene microarray data. Bioinformatics 2011, 27.
32. Jin, G., Fu, C., Zhao, H., Cui, K., Chang, J., Wong, S.T.C. A novel method of transcriptional response analysis to facilitate drug repositioning for cancer therapy. Cancer Res. 2012, 72, 33-44.
33. Iskar, M., Zeller, G., Blattmann, P., Campillos, M., Kuhn, M., Kaminska, K.H., Runz, H., Gavin, A.C., Pepperkok, R., Van Noort, V., et al. Characterization of drug-induced transcriptional modules: Towards drug repositioning and functional understanding. Mol. Syst. Biol. 2013, 9.
34. Gaiteri, C., Ding, Y., French, B., Tseng, G.C., Sibille, E. Beyond modules and hubs: The potential of gene coexpression networks for investigating molecular mechanisms of complex brain disorders. Genes Brain Behav. 2014,13,13-24.
35. Iorio, F., Rittman, T., Ge, H., Menden, M., Saez-Rodriguez, J. Transcriptional data: A new gateway to drug repositioning? Drug Discov. Today 2013,18, 350-357.
36. Sirota, M., Dudley, J.T., Kim, J., Chiang, A.P., Morgan, A.A., Sweet-Cordero, A., Sage, J., Butte, A.J. Discovery and preclinical validation of drug indications using compendia of public gene expression data (Science Translational Medicine (2011) 3, (102er)). Sci. Transl. Med. 2011, 3, 96ra77.
37. Zhao, K., So, H.-C. A machine learning approach to drug repositioning based on drug expression profiles: Applications in psychiatry. arXiv 2017, arXiv:1706.03014.
38. Wang, Y., Yella, J., Chen, J., McCormack, F.X., Madala, S.K., Jegga, A.G. Unsupervised gene expression analyses identify IPF-severity correlated signatures, associated genes and biomarkers. BMC Pulm. Med. 2017, 17.
39. Claerhout, S., Lim, J.Y., Choi, W., Park, Y.-Y., Kim, K., Kim, S.-B., Lee, J.-S., Mills, G.B., Cho, J.Y. Gene Expression Signature Analysis Identifies Vorinostat as a Candidate Therapy for Gastric Cancer. PLoS ONE 2011, 6, e24662.
40. Chang, M., Smith, S., Thorpe, A., Barratt, M.J., Karim, F. Evaluation of phenoxybenzamine in the CFA model of pain following gene expression studies and connectivity mapping. Mol. Pain 2010, 6.
41. Cai, M.C., Xu, Q., Pan, Y.J., Pan, W., Ji, N., Li, Y.B., Liu, H.J.J.K., Ji, Z.L. ADReCS: An ontology database for aiding standardization and hierarchical Classification of adverse drug reaction terms. Nucleic Acids Res. 2015, 43, D907-D913.
42. Gaulton, A., Bellis, L.J., Bento, A.P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. ChEMBL: A large-scale bioactivity database for drug discovery. Nucleic Acids Res. 2012, 40.
43. Williams, A.J. Internet-based tools for communication and collaboration in chemistry. Drug Discov. Today 2008,13, 502-506.
44. Subramanian, A., Narayan, R., Corsello, S.M., Peck, D.D., Natoli, T.E., Lu, X., Gould, J., Davis, J.F., Tubelli, A.A., Asiedu, J.K., et al. A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles. Cell 2017,171,1437-1452.
45. Mattingly, C.J., Colby, G.T., Forrest, J.N., Boyer, J.L. The Comparative Toxicogenomics Database (CTD). Environ. Health Perspect. 2003,111, 793.
46. National Institutes of Health: Health & Human Services DailyMed. Available online: http://dailymed.nlm. nih.gov/dailymed/index.cfm (accessed on 25 April 2018).
47. Griffith, M., Griffith, O.L., Coffman, A.C., Weible, J.V., Mcmichael, J.F., Spies, N.C., Koval, J., Das, I., Callaway, M.B., Eldred, J.M., et al. DGIdb: Mining the druggable genome. Nat. Methods 2013,10,1209-1210.
48. DrugBank DrugBank. Available online: http://www.drugbank.ca (accessed on 22 April 2018).
49. Ursu, O., Holmes, J., Knockel, J., Bologa, C.G., Yang, J.J., Mathias, S.L., Nelson, S.J., Oprea, T.I. DrugCentral: Online drug compendium. Nucleic Acids Res. 2017, 45, D932-D939.
50. Pihan, E., Colliandre, L., Guichou, J.F., Douguet, D. E-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design. Bioinformatics 2012, 28,1540-1541.
51. Yang, W., Soares, J., Greninger, P., Edelman, E.J., Lightfoot, H., Forbes, S., Bindal, N., Beare, D., Smith, J.A., Thompson, I.R., et al. Genomics of Drug Sensitivity in Cancer (GDSC): A resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2013, 41.
52. Koscielny, G., An, P., Carvalho-Silva, D., Cham, J.A., Fumis, L., Gasparyan, R., Hasan, S., Karamanis, N., Maguire, M., Papa, E., et al. Open Targets: A platform for therapeutic target identification and Validation. Nucleic Acids Res. 2017, 45, D985-D994.
53. Hewett, M., Oliver, D.E., Rubin, D.L., Easton, K.L., Stuart, J.M., Altman, R.B., Klein, T.E. PharmGKB: The pharmacogenetics knowledge base. Nucleic Acids Res. 2002, 30,163-165.
54. Pires, D.E.V., Blundell, T.L., Ascher, D.B. pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 2015, 58, 4066-4072.
55. Cowley, G.S., Weir, B.A., Vazquez, F., Tamayo, P., Scott, J.A., Rusin, S., East-Seletsky, A., Ali, L.D., Gerath, W.F.J., Pantel, S.E., et al. Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies. Sci. Data 2014,1.
56. Von Eichborn, J., Murgueitio, M.S., Dunkel, M., Koerner, S., Bourne, P.E., Preissner, R. PROMISCUOUS: A database for network-based drug-repositioning. Nucleic Acids Res. 2011, 39.
57. Kim, S., Thiessen, P.A., Bolton, E.E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B.A., et al. PubChem substance and compound databases. Nucleic Acids Res. 2016, 44, D1202-D1213.
58. Kuhn, M., Letunic, I., Jensen, L.J., Bork, P. The SIDER database of drugs and side effects. Nucleic Acids Res. 2016, 44, D1075-D1079.
59. Kuhn, M., von Mering, C., Campillos, M., Jensen, L.J., Bork, P. STITCH: Interaction networks of chemicals and proteins. Nucleic Acids Res. 2008, 36.
60. Dunkel, M., Günther, S., Ahmed, J., Wittig, B., Preissner, R. SuperPred: Drug classification and target prediction. Nucleic Acids Res. 2008, 36.
61. Chen, X., Ji, Z.L., Chen, Y.Z. TTD: Therapeutic Target Database. Nucleic Acids Res. 2002, 30, 412-415.
62. Wishart, D., Arndt, D., Pon, A., Sajed, T., Guo, A.C., Djoumbou, Y., Knox, C., Wilson, M., Liang, Y., Grant, J., et al. T3DB: The toxic exposome database. Nucleic Acids Res. 2015, 43, D928-D934.
63. Uhlén, M., Fagerberg, L., Hallstrom, B.M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, À., Kampf, C., Sjostedt, E., Asplund, A., et al. Proteomics. Tissue-based map of the human proteome. Science 2015, 347,1260419.
64. Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., Kanehisa, M. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 1999,27,29-34.
65. Akbarian, S., Liu, C., Knowles, J.A., Vaccarino, F.M., Farnham, P.J., Crawford, G.E., Jaffe, A.E., Pinto, D., Dracheva, S., Geschwind, D.H., et al. The PsychENCODE project. Nat. Neurosci. 2015, 18, 1707-1712.
66. Sunkin, S.M., Ng, L., Lau, C., Dolbeare, T., Gilbert, T.L., Thompson, C.L., Hawrylycz, M., Dang, C. Allen Brain Atlas: An integrated spatio-temporal portal for exploring the central nervous system. Nucleic Acids Res. 2013, 41, D996-D1008.
67. Parkinson, H. ArrayExpress-a public repository for microarray gene expression data at the EBI. Nucleic Acids Res. 2004, 33, D553-D555.
68. Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A.A; Kim, S., Wilson, C.J., Lehar, J., Kryukov, G.V; Sonkin, D., et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity Supp. Nature 2012, 483, 603-607.
69. Forbes, S.A., Beare, D., Gunasekaran, P., Leung, K., Bindal, N., Boutselakis, H., Ding, M., Bamford, S., Cole, C., Ward, S., et al. COSMIC: Exploring the world's knowledge of somatic mutations in human cancer. Nucleic Acids Res. 2015, 43, D805-D811.
70. Mailman, M.D., Feolo, M., Jin, Y., Kimura, M., Tryka, K., Bagoutdinov, R., Hao, L., Kiang, A., Paschall, J., Phan, L., et al. The NCBI dbGaP database of genotypes and phenotypes. Nat. Genet. 2007, 39,1181-1186.
71. Sherry, S.T. dbSNP: The NCBI database of genetic variation. Nucleic Acids Res. 2001, 29, 308-311.
72. Lappalainen, I., Lopez, J., Skipper, L., Hefferon, T., Spalding, J.D., Garner, J., Chen, C., Maguire, M., Corbett, M., Zhou, G., et al. DbVar and DGVa: Public archives for genomic structural variation. Nucleic Acids Res. 2013, 41.
73. Pinero, J., Queralt-Rosinach, N., Bravo, À., Deu-Pons, J., Bauer-Mehren, A., Baron, M., Sanz, F., Furlong, L.I. DisGeNET: A discovery platform for the dynamical exploration of human diseases and their genes. Database 2015, 2015.
74. Grossman, R.L., Heath, A.P., Ferretti, V., Varmus, H.E., Lowy, D.R., Kibbe, W.A., Staudt, L.M. Toward a Shared Vision for Cancer Genomic Data. N. Engl. J. Med. 2016, 375,1109-1112.
75. Barrett, T. NCBI GEO: Mining millions of expression profiles-database and tools. Nucleic Acids Res. 2004, 33, D562-D566.
76. Lonsdale, J., Thomas, J., Salvatore, M., Phillips, R., Lo, E., Shad, S., Hasz, R., Walters, G., Garcia, F., Young, N., et al. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 2013, 45, 580-585.
77. Kim, M.-S., Pinto, S.M., Getnet, D., Nirujogi, R.S., Manda, S.S., Chaerkady, R., Madugundu, A.K., Kelkar, D.S., Isserlin, R., Jain, S., et al. A draft map of the human proteome. Nature 2014, 509, 575-581.
78. Cancer, T. International Cancer Genome Consortium. Cancer 2011, 2011,1-20.
79. Clarke, L., Fairley, S., Zheng-Bradley, X., Streeter, I., Perry, E., Lowy, E., Tassé, A.M., Flicek, P. The international Genome sample resource (IGSR): A worldwide collection of genome variation incorporating the 1000 Genomes Project data. Nucleic Acids Res. 2017, 45, D854-D859.
80. Aymé, S., Schmidtke, J. Networking for rare diseases: A necessity for Europe. Bundesgesundheitsblatt Gesundheitsforschunq Gesundheitsschutz 2007, 50,1477-1483.
81. Bernstein, B.E., Stamatoyannopoulos, J.A., Costello, J.F., Ren, B., Milosavljevic, A., Meissner, A., Kellis, M., Marra, M.A., Beaudet, A.L., Ecker, J.R., et al. The NIH roadmap epigenomics mapping consortium. Nat. Biotechnol. 2010, 28,1045-1048.
82. Szklarczyk, D., Franceschini, A., Kuhn, M., Simonovic, M., Roth, A., Minguez, P., Doerks, T., Stark, M., Muller, J., Bork, P., et al. The STRING database in 2011: Functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2011, 39.
83. Lamb, J., Crawford, E.D., Peck, D., Modell, J.W., Blat, I.C., Wrobel, M.J., Lerner, J., Brunet, J.P., Subramanian, A., Ross, K.N., et al. The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease. Science 2006, 313,1929-1935.
84. Musa, A., Ghoraie, L.S., Zhang, S.-D., Galzko, G., Yli-Harja, O., Dehmer, M., Haibe-Kains, B., Emmert-Streib, F. A review of connectivity map and computational approaches in pharmacogenomics. Brief. Bioinform. 2017, bbw112.
85. Angermueller, C., Parnamaa, T., Parts, L., Oliver, S. Deep Learning for Computational Biology. Mol. Syst. Biol. 2016, 878.
86. Gottlieb, A., Stein, G.Y., Ruppin, E., Sharan, R. PREDICT: A method for inferring novel drug indications with application to personalized medicine. Mol. Syst. Biol. 2011, 7.
87. Liu, Z., Guo, F., Gu, J., Wang, Y., Li, Y., Wang, D., Lu, L., Li, D., He, F. Similarity-based prediction for Anatomical Therapeutic Chemical classification of drugs by integrating multiple data sources. Bioinformatics 2015, 31, 1788-1795.
88. Li, J., Lu, Z. A new method for computational drug repositioning using drug pairwise similarity. In Proceedings of the 2012 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2012, Philadelphia, PA, USA, 4-7 October 2012; pp. 453-456.
89. Luo, H., Wang, J., Li, M., Luo, J., Peng, X., Wu, F.X., Pan, Y. Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm. Bioinformatics 2016, 32,2664-2671.
90. Oh, M., Ahn, J., Yoon, Y. A network-based classification model for deriving novel drug-disease associations and assessing their molecular actions. PLoS ONE 2014, 9.
91. Mamoshina, P., Vieira, A., Putin, E., Zhavoronkov, A. Applications of Deep Learning in Biomedicine. Mol. Pharm. 2016,13,1445-1454.
92. Lecun, Y., Bengio, Y., Hinton, G. Deep learning. Nature 2015, 521, 436-444.
93. Aliper, A., Plis, S., Artemov, A., Ulloa, A., Mamoshina, P., Zhavoronkov, A. Deep learning applications for predicting pharmacological properties of drugs and drug repurposing using transcriptomic data. Mol. Pharm. 2016,13, 2524-2530.
94. Unterthiner, T., Mayr, A., Klambauer, G., Hochreiter, S. Toxicity Prediction using Deep Learning. Front. Environ. Sci. 2015, 3,10.
95. Ramsundar, B., Kearnes, S., Riley, P., Webster, D., Konerding, D., Pande, V. Massively Multitask Networks for Drug Discovery. arXiv 2015, arXiv:1502.02072.
96. Schadt, E.E. Molecular networks as sensors and drivers of common human diseases. Nature 2009, 461, 218-223.
97. Azuaje, F. Drug interaction networks: An introduction to translational and clinical applications. Cardiovasc. Res. 2013, 97, 631-641.
98. Ye, H., Liu, Q., Wei, J. Construction of drug network based on side effects and its application for drug repositioning. PLoS ONE 2014, 9.
99. Mizutani, S., Pauwels, E., Stoven, V., Goto, S., Yamanishi, Y. Relating drug-protein interaction network with drug side effects. Bioinformatics 2012,28.
100. Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L.J., Bork, P. Drug target identification using side-effect similarity. Science 2008, 321, 263-266.
101. Brown, A.S., Kong, S.W., Kohane, I.S., Patel, C.J. ksRepo: A generalized platform for computational drug repositioning. BMC Bioinform. 2016,17.
102. Setoain, J., Franch, M., Martinez, M., Tabas-Madrid, D., Sorzano, C.O.S., Bakker, A., Gonzalez-Couto, E., Elvira, J., Pascual-Montano, A. NFFinder: An online bioinformatics tool for searching similar transcriptomics experiments in the context of drug repositioning. Nucleic Acids Res. 2015, 43, W193-W199.
103. Chang, R., Shoemaker, R., Wang, W. A novel knowledge-driven systems biology approach for phenotype prediction upon genetic intervention. IEEE/ACM Trans. Comput. Biol. Bioinform. 2011, 8, 1170-1182.
104. Chen, H., Zhang, H., Zhang, Z., Cao, Y., Tang, W. Network-based inference methods for drug repositioning. Comput. Math. Methods Med. 2015,2015.
105. Wu, C., Gudivada, R.C., Aronow, B.J., Jegga, A.G. Computational drug repositioning through heterogeneous network clustering. BMC Syst. Biol. 2013, 7,1-9.
106. Chen, J., Bardes, E.E., Aronow, B.J., Jegga, A.G. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 2009, 37.
107. Luo, Y., Zhao, X., Zhou, J., Yang, J., Zhang, Y., Kuang, W., Peng, J., Chen, L., Zeng, J. A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information. Nat. Commun.2017, 8.
108. Himmelstein, D.S., Lizee, A., Hessler, C., Brueggeman, L., Chen, S.L., Hadley, D., Green, A., Khankhanian, P., Baranzini, S.E. Systematic integration of biomedical knowledge prioritizes drugs for repurposing. eLife 2017, 6.1-35.
109. Luo, Y., Thompson, W.K., Herr, T.M., Zeng, Z., Berendsen, M.A., Jonnalagadda, S.R., Carson, M.B., Starren, J. Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review. Drug Saf. 2017, 40, 1075-1089.
110. Xu, H., Aldrich, M.C., Chen, Q., Liu, H., Peterson, N.B., Dai, Q., Levy, M., Shah, A., Han, X., Ruan, X., et al. Validating drug repurposing signals using electronic health records: A case study of metformin associated with reduced cancer mortality. J. Am. Med. Inform. Assoc. 2014,1-10.
111. Brown, A.S., Patel, C.J. A review of validation strategies for computational drug repositioning. Brief. Bioinform. 2018,19,174-177.
112. Lee, W.H. Open access target validation is a more efficient way to accelerate drug discovery. PLoS Biol. 2015, 13.1-9.
113. Carter, A.J., Donner, A., Lee, W.H., Bountra, C. Establishing a reliable framework for harnessing the creative power of the scientific crowd. PLoS Biol. 2017,15.
114. Rijnders, T.W., Tzalis, D., Jaroch, S. The European lead factory-An experiment in colla-borative drug discovery. J. Med. Dev. Sci. 2015,1, 20-33.
115. Munos, B. Can open-source drug RD repower pharmaceutical innovation? Clin. Pharmacol. Ther. 2010, 87, 534-536.
116. Lakhani, K.R., Boudreau, K.J., Loh, P.R., Backstrom, L., Baldwin, C., Lonstein, E., Lydon, M., MacCormack, A., Arnaout, R.A., Guinan, E.C. Prize-based contests can provide solutions to computational biology problems. Nat. Biotechnol. 2013, 31,108-111.
117. Bentzien, J., Muegge, I., Hamner, B., Thompson, D.C. Crowd computing: Using competitive dynamics to develop and refine highly predictive models. Drug Discov. Today 2013,18, 472-478.
118. Patel, A.C., Coyle, A.J. Building a new biomedical ecosystem: Pfizer's centers for therapeutic innovation. Clin. Pharmacol. Ther. 2013, 94, 314-316.
119. Wang, Z., Monteiro, C.D., Jagodnik, K.M., Fernandez, N.F., Gundersen, G.W., Rouillard, A.D., Jenkins, S.L., Feldmann, A.S., Hu, K.S., McDermott, M.G., et al. Extraction and analysis of signatures from the Gene Expression Omnibus by the crowd. Nat. Commun. 2016, 7.
120. Dorsch, H., Jurock, A.E., Schoepe, S., Lessl, M., Asadullah, K. Grants4Targets: An open innovation initiative to foster drug discovery collaborations. Nat. Rev. Drug Discov. 2014,14, 74.
121. Markoff, J. Scientists see advances in deep learning. New York Times 2012.
122. Alvim-Gaston, M., Grese, T., Mahoui, A., Palkowitz, A., Pineiro-Nunez, M., Watson, I. Open Innovation Drug Discovery (OIDD): A Potential Path to Novel Therapeutic Chemical Space. Curr. Top. Med. Chem. 2014, 14, 294-303.
123. Margolin, A.A., Bilal, E., Huang, E., Norman, T.C., Ottestad, L., Mecham, B.H., Sauerwine, B., Kellen, M.R., Mangravite, L.M., Furia, M.D., et al. Systematic analysis of challenge-driven improvements in molecular prognostic models for breast cancer. Sci. Transl. Med. 2013, 5.
124. Aksulu, A., Wade, M. A Comprehensive Review and Synthesis of Open Source Research. J. Assoc. Inf. Syst. 2010, 11, 576-656.
125. Stajich, J.E., Lapp, H. Open source tools and toolkits for bioinformatics: Significance, and where are we? Brief. Bioinform. 2006, 7, 287-296.
126. Kluyver, T., Ragan-kelley, B., Pérez, F., Granger, B., Bussonnier, M., Frederic, J., Kelley, K., Hamrick, J., Grout, J., Corlay, S., et al. Jupyter Notebooks-A publishing format for reproducible computational workflows. Position. Power Acad. Publ. Play. Agents Agendas 2016, 87-90.
127. Pedregosa, F., Varoquaux, G., Gramfort, A., Michel, V., Thirion, B., Grisel, O., Blondel, M., Prettenhofer, P., Weiss, R., Dubourg, V., et al. Scikit-learn: Machine Learning in Python. J. Mach. Learn. Res. 2011, 12, 2825-2830.
128. Demsar, J., Curk, T., Erjavec, A., Hocevar, T., Milutinovic, M., Mozina, M., Polajnar, M., Toplak, M., Staric, A., Stajdohar, M., et al. Orange: Data Mining Toolbox in Python. J. Mach. Learn. Res. 2013,14, 2349-2353.
129. Hall, M.A., Frank, E., Holmes, G., Pfahringer, B., Reutemann, P., Witten, I.H. The WEKA data mining software: An update. SIGKDD Explor. 2009,11,10-18.
130. Abadi, M., Barham, P., Chen, J., Chen, Z., Davis, A., Dean, J., Devin, M., Ghemawat, S., Irving, G., Isard, M., et al. TensorFlow: A System for Large-Scale Machine Learning TensorFlow: A system for large-scale machine learning. In Proceedings of the 12th USENIX Symposium on Operating Systems Design and Implementation (OSDI '16), Savannah, Georgia, 22 August 2016; pp. 265-284.
131. Chollet, F. Keras. Available online: https://github.com/fchollet/keras (accessed on 23 April 2018).
132. Paszke, A., Chanan, G., Lin, Z., Gross, S., Yang, E., Antiga, L., Devito, Z. Automatic differentiation in PyTorch. Adv. Neural Inf. Process. Syst. 2017, 30,1-4.
133. Yu, D., Huang, X. Microsoft Computational Network Toolkit (CNTK). In Neural Information Processing Systems (NIPS); Palais des Congrès de Montréal: Montréal, QC, Canada, 2015.
134. Vedaldi, A., Lenc, K. MatConvNet-Convolutional Neural Networks for MATLAB. arXiv 2014, arXiv:1412.4564.
135. Bastian, M., Heymann, S., Jacomy, M. Gephi: An Open Source Software for Exploring and Manipulating Networks. In Proceedings of the Third International AAAI Conference on Weblogs and Social Media, San Jose, CA, USA, 17-20 May 2009; pp. 361-362.
136. Shannon, P., Markiel, A., Ozier, O., Baliga, N.S., Wang, J.T., Ramage, D., Amin, N., Schwikowski, B., Ideker, T. Cytoscape: A software Environment for integrated models of biomolecular interaction networks. Genome Res. 2003,13, 2498-2504.
137. Corsello, S.M., Bittker, J.A., Liu, Z., Gould, J., McCarren, P., Hirschman, J.E., Johnston, S.E., Vrcic, A., Wong, B., Khan, M., et al. The Drug Repurposing Hub: A next-generation drug library and information resource. Nat. Med. 2017, 23, 405-408.
138. Jia, Z., Liu, Y., Guan, N., Bo, X., Luo, Z., Barnes, M.R. Cogena, a novel tool for co-expressed gene-set enrichment analysis, applied to drug repositioning and drug mode of action discovery. BMC Genomics 2016, 17.
139. Altae-Tran, H., Ramsundar, B., Pappu, A.S., Pande, V. Low Data Drug Discovery with One-Shot Learning. ACS Cent. Sci. 2017, 3, 283-293.
140. Zhou, H., Gao, M., Skolnick, J. Comprehensive prediction of drug-protein interactions and side effects for the human proteome. Sci. Rep. 2015, 5.
141. Douguet, D. e-LEA3D: A computational-aided drug design web server. Nucleic Acids Res. 2010,38.
142. Miteva, M.A., Guyon, F., Tufféry, P. Frog2: Efficient 3D conformation ensemble generator for small compounds. Nucleic Acids Res. 2010, 38.
143. Zu, S., Chen, T., Li, S. Global optimization-based inference of chemogenomic features from drug-target interactions. Bioinformatics 2015, 31, 2523-2529.
144. Louhimo, R., Laakso, M., Belitskin, D., Klefström, J., Lehtonen, R., Hautaniemi, S. Data integration to prioritize drugs using genomics and curated data. BioData Min. 2016, 9.
145. Steinbeck, C., Han, Y., Kuhn, S., Horlacher, O., Luttmann, E., Willighagen, E. The Chemistry Development Kit (CDK): An open-source Java library for chemo-and bioinformatics. J. Chem. Inf. Comput. Sci. 2003, 43, 493-500.
146. Duan, Q., Reid, S.P., Clark, N.R., Wang, Z., Fernandez, N.F., Rouillard, A.D., Readhead, B., Tritsch, S.R., Hodos, R., Hafner, M., et al. L1000CDS2: LINCS L1000 characteristic direction signatures search engine. NPJ Syst. Biol. Appl. 2016, 2,16015.
147. Carrella, D., Napolitano, F., Rispoli, R., Miglietta, M., Carissimo, A., Cutillo, L., Sirci, F., Gregoretti, F., Di Bernardo, D. Mantra 2.0: An online collaborative resource for drug mode of action and repurposing by network analysis. Bioinformatics2014, 30,1787-1788.
148. O'Boyle, N.M., Banck, M., James, C.A., Morley, C., Vandermeersch, T., Hutchison, G.R. Open Babel: An Open chemical toolbox. J. Cheminform. 2011, 3.
149. Williams, A.J., Harland, L., Groth, P., Pettifer, S., Chichester, C., Willighagen, E.L., Evelo, C.T., Blomberg, N., Ecker, G., Goble, C., et al. Open PHACTS: Semantic interoperability for drug discovery. Drug Discov. Today 2012,17,1188-1198.
150. Garfield, E. The Who and Why of ISI. Essays of Information Scientist. 1966. Available online: http://garfield. library.upenn.edu/essays/V1p033y1962-73.pdf (accessed on 1 June 2018).
151. Repeat after me. Nature 2012, 488, 253.
152. Begley, C.G., Ellis, L.M. Drug development: Raise standards for preclinical cancer research. Nature 2012, 483, 531-533.
153. Baker, M. Irreproducible biology research costs put at $28 billion per year. Nature 2015.
154. Peng, R.D. Reproducible research in computational science. Science 2011, 334, 1226-1227.
155. Gentleman, R. Reproducible Research: A Bioinformatics Case Study. Stat. Appl. Genet. Mol. Biol. 2005, 4.
156. Guney, E. Reproducible Drug Repurposing: When Similarity Does Not Suffice. Pac. Symp. Biocomput. 2016, 22,132-143.
157. Wilkinson, M.D., Dumontier, M., Aalbersberg, I.J., Appleton, G., Axton, M., Baak, A., Blomberg, N., Boiten, J.-W., da Silva Santos, L.B., Bourne, P.E., et al. The FAIR Guiding Principles for scientific data management and stewardship. Sci. Data 2016, 3,160018.
158. Torre, D., Krawczuk, P., Jagodnik, K.M., Lachmann, A., Wang, Z., Wang, L., Kuleshov, M.V., Ma'Ayan, A. Datasets2Tools, repository and search engine for bioinformatics datasets, tools and canned analyses. Sci. Data 2018,5.
159. Ram, K. Git can facilitate greater reproducibility and increased transparency in science. Source Code Biol. Med. 2013, 8.
160. Merkel, D. Docker: Lightweight Linux containers for consistent development and deployment. Linux J. 2014, 2014, 2.